Ling Zhu

Ling Zhu

Auto-generated profile, based on publicly available information

Ling Zhu

Medical Technology Department, Sichuan Nursing Vocational College, Chengdu, Sichuan, People’s Republic of China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2025 in Clinical, Cosmetic and Investigational Dermatology
Verified
Journal Article
Open access
PDF file
YNYanchao Niu
Yanchao Niu
LZLing Zhu
Ling Zhu
YFYanyan Feng
Yanyan Feng
ZLZaibing Li
Zaibing Li
JZJian Zhang
Jian Zhang
CRCi Ren
Ci Ren
Objective: To explore the efficacy of Follicular Unit Excision (FUE) in treating pediatric secondary cicatricial alopecia. Methods: We selected 11 cases of patients under 18 years old who underwent treatment for secondary cicatricial alopecia at the Chengdu Hengmei Hair Medical Clinic from January 1, 2021, to December 31, 2022. Among them, there was 1 female and 10 males. All patients underwent FUE procedures. After 12 months, the assessment of the surgical efficacy was evaluated using the Global Aesthetic Improvement Scale (GAIS), and the incidence of complications was recorded. Results: Among the 11 patients, none experienced complications such as infection, skin necrosis, significant hematoma, unnatural appearance, or temporary hair loss. 6 cases (54.5%) were rated as 1 on the GAIS, indicating extreme satisfaction. 2 cases (18.2%) were rated as 2, signifying satisfaction, resulting in an overall satisfaction rate of 72.7%. 1 case (9.1%) scored 3, showing limited improvement and dissatisfaction, and 2 cases (18.2%) scored 4, indicating no improvement. Conclusion: FUE hair transplantation is a safe, minimally invasive, and effective method for treating stable cicatricial alopecia in children, leading to significant aesthetic improvements for the patients. Further studies with larger cohorts are needed to confirm these results and explore long-term outcomes.

31 January 2022 in Frontiers in Oncology
Verified
Journal Article
Open access
DZDan Zhu
Dan Zhu
XDXiaoqing Dai
Xiaoqing Dai
JWJingbo Wang
Jingbo Wang
CZChunye Zhang
Chunye Zhang
XTXiaofeng Tao
Xiaofeng Tao
LZLing Zhu
Ling Zhu
Objectives: To assess computed tomography (CT) and magnetic resonance imaging (MRI) findings of intramuscular hemangiomas (IMHs) in oral and maxillofacial region and correlate them with the histopathological classifications for selecting optimum management.Methods: The clinical data and pretreatment findings of 32 patients with pathologically proven IMHs on CT (n = 10), MRI (n = 27), or both (n = 5) were analyzed retrospectively. Correspondence of clinical and imaging characters with 3 different pathological classifications (cavernous, capillary, and mixed) of IMHs was studied. A number of pitfalls and overlap of imaging features can result in misdiagnosis of different IMHs lesions.Results: Four patients had multi-muscular lesions, and 28 had single-muscular lesions. The predilection site were the tongue (11 cases, 34.4%) and the masseter muscle (10 cases, 31.2%). Cavernous type (17 cases, 53.1%) was the most common IMHs type. All patients showed slightly hypointense or isointense on T1-weighted imaging, 3 patients showed hyperintense on T2-weighted imaging and the others showed slightly hyperintense. The most common enhancement pattern was progressive (29 cases, 90.6%). The capillary type (9 cases, 28.1%) and mixed type (6 cases, 28.1%) of IMHs on imaging indicated characteristics of lesions with rich blood supply status, the cavernous type (17cases, 53.1%) of IMHs belonged to relatively poor blood supply lesions. A total of 5 patients (15.6%) were initially misdiagnosed, there were recurrences in 4 IMHs patients. Extra functional MRI (fMRI) was performed on these 5 misdiagnosed patients, the average ADC of the 5 patients was 1.50 × 10−3 mm2/s. The presence of vermicular vessels was different among these three types of IMHs.Conclusions: The reason for the misdiagnosis in localized IMHs may be the obvious border of mass-like lesions and the lack of enlarged vessels. Combined evaluation of presence of vermicular vessels and fMRI might be more accurately for determining the IMHs and create a preoperative plan.

1 April 2026 in Clinical Interventions in Aging
Verified
Journal Article
Open access
LJLan Jiang
Lan Jiang
LZLing Zhu
Ling Zhu
YJYifeng Jin
Yifeng Jin
MYMeirong Yao
Meirong Yao
To compare outcomes between non-operative and operative management of hip fractures in elderly patients. In this single-center retrospective cohort study (January 2018–December 2022), we enrolled 298 elderly patients with hip fractures after excluding 704 from an initial 1,002 consecutive cases. This study excluded patients with old fractures, other types of fractures, lack of data on injury reason, and absence of follow-up data. Multivariable logistic regression was used to explore the association between different treatment and mortality, adjusting for age, gender, injury reason, fracture type, hypertension, and diabetes. Subgroup analyses were employed to assess the association between the different treatments and mortality. Among the 298 elderly patients with hip fractures, 59 were managed non-operatively and 239 underwent surgery. The overall 1-year mortality rate was 14.43% (43/298). Mortality was 25.42% (15/59) in the non-operative group and 11.72% (28/239) in the operative group. After adjustment, surgical management reduced mortality risk by 61% (OR =0.39, 95% CI:0.19–0.82, P = 0.013). Subgroup analysis demonstrated significant benefit in patients < 80 years (87% risk reduction; OR = 0.13, 95% CI: 0.04–042), whereas no significant association was observed in ≥ 80-year-olds (OR = 0.85, 95% CI:0.32–2.80, P for interaction = 0.023). Our analysis indicates an association between operative management and reduced mortality risk in elderly hip fracture patients. This benefit was observed to be more marked in individuals aged under 80 years. While consistent with existing observational studies, these findings merit confirmation through randmised controlled trials, particularly to determine optimal management strategies for the oldest old (≥80 years).